Provided by Tiger Fintech (Singapore) Pte. Ltd.

RxSIGHT, INC.

14.53
-0.0950-0.65%
Volume:976.97K
Turnover:14.32M
Market Cap:588.13M
PE:-20.56
High:14.93
Open:14.65
Low:14.45
Close:14.62
Loading ...

Rxsight Inc: Qtrly Shr Loss $0.15

THOMSON REUTERS
·
26 Feb

Rxsight Q4 Operating Expenses USD 37.4 Million

THOMSON REUTERS
·
26 Feb

Stifel Nicolaus Remains a Hold on RxSight (RXST)

TIPRANKS
·
18 Feb

RxSight, Inc. to Report Fourth Quarter Financial Results on February 25, 2025

GlobeNewswire
·
12 Feb

Insider Stock Buying Reaches US$1.83m On RxSight

Simply Wall St.
·
02 Feb

RxSight price target lowered to $43 from $66 at Needham

TIPRANKS
·
17 Jan

RxSight Price Target Maintained With a $66.00/Share by Needham

Dow Jones
·
13 Jan

Rxsight Inc : Wells Fargo Cuts Target Price to $40 From $42

THOMSON REUTERS
·
13 Jan

RxSight: Balanced Outlook Amid Mixed Q4 Performance and Revised Valuation

TIPRANKS
·
13 Jan

RxSight’s Promising Growth Fueled by Strong Market Performance and Strategic Expansion

TIPRANKS
·
13 Jan

Positive Outlook for RxSight: Strong Revenue and Margin Projections Justify Buy Rating

TIPRANKS
·
13 Jan

RxSight Reports Preliminary Q4 Revenue, Issues 2025 Outlook

MT Newswires Live
·
13 Jan

Analysts Offer Insights on Healthcare Companies: RxSight (RXST), Health Catalyst (HCAT) and Amicus (FOLD)

TIPRANKS
·
13 Jan

RxSight’s Promising Growth and Profitability Prospects Earn a ‘Buy’ Rating

TIPRANKS
·
13 Jan

BTIG Sticks to Its Buy Rating for RxSight (RXST)

TIPRANKS
·
13 Jan

BRIEF-Rxsight Q4 Revenue USD 40.2 Million Vs. IBES Estimate USD 40.4 Million

Reuters
·
12 Jan

Rxsight Outlook FY Revenue USD 185-197 Million

THOMSON REUTERS
·
12 Jan

RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2024 Financial and Operational Results and 2025 Guidance

GlobeNewswire
·
12 Jan

Analysts’ Top Healthcare Picks: RxSight (RXST), Pacific Biosciences (PACB)

TIPRANKS
·
07 Jan

RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference

GlobeNewswire
·
03 Jan